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Abstract
Background: Indonesia has the highest human mortality from highly pathogenic avian influenza 
(HPAI) A (H5N1) virus infection in the world.
Methods: A survey of households (N = 2520) measured treatment sources and beliefs among 
symptomatic household members. A survey of physicians (N = 554) in various types of health care 
facilities measured knowledge, assessment and testing behaviors, and perceived clinical capacity.
Results: Households reported confidence in health care system capacity but infrequently sought 
treatment for potential HPAI H5N1 signs/symptoms. More clinicians were confident in their 
knowledge of diagnosis and treatment than in the adequacy of related equipment and resources at 
their facilities. Physicians expressed awareness of the HPAI H5N1 suspect case definition, yet 
expressed only moderate knowledge in questioning symptomatic patients about exposures. Self-
reported likelihood of testing for HPAI H5N1 virus was high after learning of certain exposures. 
Knowledge of antiviral treatment was moderate, but it was higher among clinicians in puskesmas. 
Physicians in private outpatient clinics, the most heavily used facilities, reported the lowest 
confidence in their diagnostic and treatment capabilities.
Conclusions: Educational campaigns can encourage recall of possible poultry exposure when 
patients are experiencing signs/symptoms and can raise awareness of the effectiveness of antivirals 
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to drive people to seek health care. Clinicians may benefit from training regarding exposure 
assessment and referral procedures, particularly in private clinics.
Keywords
health care utilization; delivery of health care; influenza A virus (H5N1 subtype); health 
communication; Indonesia
Indonesia accounted for 199 of the 850 reported human cases of highly pathogenic avian 
influenza (HPAI) A(H5N1) occurring globally between November 2003 and April 2016.1 
Cumulative mortality from the virus is substantially higher in Indonesia (83.9%) compared 
with the global case fatality proportion (53.1%).1 Signs and symptoms of HPAI H5N1 virus 
infection are often nonspecific, initially appearing as an influenza-like illness or pneumonia.
2
 Fever (temperature ≥38°C) and cough are observed in most patients, and they may be 
accompanied by difficulty breathing. Risk factors for mortality associated with HPAI H5N1 
virus infection are late initiation or no antiviral treatment, delayed presentation to health 
care, and delayed clinical suspicion of HPAI H5N1 virus infection.3–5 Early antiviral therapy 
(within 2 days of onset of signs and symptoms) has been shown to be the most effective 
treatment.4,6 Ill persons who meet the case definition for suspected HPAI H5N1 in Indonesia 
are routed through a hospital referral system for intensive care and case management. The 
suspect case definition for HPAI H5N1 includes patients presenting with fever (≥38°C), 
cough, sore throat, and shortness of breath, as well as recent exposure to poultry or 
suspected human cases within the previous 7 days.7 Currently, there are 100 HPAI H5N1 
referral hospitals throughout the country that are supplied with antivirals (oseltamivir) for 
treatment and management of patients with suspected HPAI H5N1 transferred from other 
facilities.8 Oseltamivir is administered in strongly suspected or confirmed cases of HPAI 
H5N1 according to national clinical guidelines.9
Interventions to reduce HPAI H5N1 virus transmission between poultry and humans have 
sought to encourage the adoption of protective behaviors and biosecurity standards among 
Indonesian poultry producers and consumers.10 Simultaneous efforts have increased 
individuals’ recognition of potential HPAI H5N1 signs and symptoms and encouraged 
people to seek health care promptly. Raising public awareness of the need for prompt 
medical treatment in the event of potential HPAI H5N1 virus infection necessitates health 
care provider readiness and health system capacity. Additionally, it is important to determine 
health care providers’ ability to recognize indicators of HPAI H5N1 virus infection, 
particularly because people may seek treatment for influenza-like illness without being 
aware of the possibility of HPAI H5N1 virus infection. Attempts to reduce the case fatality 
proportion of HPAI H5N1 patients in Indonesia must consider the role of HPAI H5N1–
related knowledge and practices among clinicians, as well as any barriers they perceive in 
providing prompt and effective treatment for symptomatic patients.
Poultry contact is common among patients seeking treatment for respiratory disease in 
Jakarta. Between October 2011 and September 2012, 34% of 3278 patients with influenza-
like illness and 21% of 1787 patients with severe acute respiratory infection reported poultry 
contact in the previous 7 days.11 A smaller proportion (12% of patients with influenza-like 
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illness and 8% of patients with severe acute respiratory infection) reported exposures to 
poultry that met the suspected case definition for HPAI H5N1 in Indonesia (touching sick or 
dead poultry, touching poultry products, killing/slaughtering poultry, or contact with chicken 
manure).11
A previous study on health care–seeking behaviors for respiratory illness among households 
in the Java districts of East Jakarta and Bogor found that nearly two-thirds (61%) of 
households with mild respiratory symptoms self-treat using home care and/or obtain 
medication from pharmacies rather than seeking care at a health care facility. Additionally, 
households that experienced severe respiratory illness were evenly divided between those 
opting for self-care and those seeking treatment at a health care facility (47% for each), and 
hospitalizations for these symptoms were rare.12 It is unclear how perceptions of health care 
services and HPAI H5N1 risk informed decisions to self-treat or seek care and to what extent 
these perceptions are accurate.
While clinician knowledge and practices for seasonal influenza, the 2009 pandemic H1N1, 
and HPAI H5N1 in Indonesia have been previously reported,13 the literature is lacking 
information on clinicians’ own assessments of their HPAI H5N1 knowledge and treatment 
capacity, whether clinical capacity varies by location in Indonesia, and whether capacity is 
sufficient in facilities where patients are most likely to seek care for potential HPAI H5N1 
illness. The purpose of this study is therefore to investigate perspectives about the health 
care system among household respondents who experienced signs/symptoms of potential 
HPAI H5N1 virus infection. The study will then describe clinicians’ knowledge, practices, 
and clinical capacity related to HPAI H5N1 in the various types of health care facilities used 
by the public.
METHODS
Health Care Utilization Survey
Data on the public’s use of health care facilities were obtained from a health care utilization 
survey (HUS) (N = 2520), a population-based face-to-face survey of households in urban 
East Jakarta District (DKI Jakarta) and rural Bogor District in West Java (conducted 
February 8 to March 1, 2012). The West Java region was selected because it is an area with 
intensive large-scale poultry production, household rearing of poultry, and a relatively high 
prevalence of human cases of HPAI H5N1.10 Subdistricts in East Jakarta were identified 
using a purposive sampling design, and comparison areas in Bogor were sampled using 
probability proportionate to size. Population-normalized weights based on the sample design 
used in each district were applied to statistical analyses. Surveys were administered to the 
adult who was most knowledgeable about the health conditions of household members using 
face-to-face interviews conducted in the Bahasa Indonesia language.
The survey assessed health care facilities used by households if members had ever 
experienced nonspecific (sudden fever/cough) or acute (sudden fever/cough plus difficulty 
breathing) symptoms of influenza-like illness. Respondents who had ever experienced signs/
symptoms in their household reported use of health care facilities (outpatient community 
health centers known as puskesmas, government hospital, private hospital, or private 
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outpatient clinic), purchasing treatments at a pharmacy, visiting traditional healers, self-care 
(medicine or fluids at home), or doing nothing. Respondents who sought treatment at a 
health care facility indicated their reasons for choosing a given facility (answering yes or no 
to each provided reason).
All respondents, regardless of illness history, were asked questions about perceptions of 
health care services and intentions to seek treatment in hypothetical scenarios where they 
developed HPAI H5N1 signs/symptoms. Confidence in their health care provider’s ability to 
treat HPAI H5N1 (“If I have avian flu, I am confident that my health care provider will give 
me the proper treatment”) and belief that visiting puskesmas facilities can prevent HPAI 
H5N1 mortality (“People infected with avian flu can recover if brought to the puskesmas 
quickly”) were measured on a 6-point Likert-type scale (0 = completely disagree, 5 = 
completely agree). Respondents reported their intention to seek treatment on a 6-point 
Likert-type scale (0 = not at all likely, 5 = very likely) if they were to develop: fever; fever 
and cough; fever, sore throat, and difficulty breathing; fever, sore throat, and difficulty 
breathing after having contact with birds in the previous 2 weeks; fever, sore throat, and 
difficulty breathing after having been to a wet market in the previous 2 weeks. (“Wet 
markets” are commonly used live-animal markets that slaughter and sell poultry, fish, 
mammals, and reptiles directly to consumers.) Respondents were asked whether a health 
care provider had ever wanted to test them for avian flu and whether they had ever requested 
testing for it (yes/no). All respondents were asked if they had ever heard of oseltamivir; 
persons responding “yes” were asked whether they believed it was effective in treating avian 
flu (yes/no/don’t know).
Human subjects review for the HUS study was conducted and approved by the Ethics 
Committee of the Faculty of Public Health, University of Indonesia, with additional approval 
by the Centers for Disease Control and Prevention Institutional Review Board, Atlanta, 
Georgia.
Clinician Knowledge, Attitudes, and Practices Survey
This study used data from a cross-sectional survey, conducted between March 2012 and June 
2012, of licensed physicians in health care facilities (outpatient community health centers 
known as puskesmas, government hospitals, private hospitals, and private outpatient clinics). 
Participants were selected using purposive sampling to identify general practitioners and 
subspecialists from a list of registered physicians from the District Health Offices in Jakarta 
and Bogor. Face-to-face structured interviews were conducted in the Bahasa Indonesia 
language by study personnel.
The survey instrument measured knowledge of: the World Health Organization suspect 
HPAI H5N1 case definition for Indonesia; influenza clinical management practices such as 
antiviral treatment and referral procedures; risk factors for illness and death from HPAI 
H5N1 virus infection; and self-reported likelihood of testing for HPAI H5N1 virus based on 
signs/symptoms and history of recent poultry exposures. To classify as a suspected HPAI 
H5N1 case as defined by the Indonesian Ministry of Health (slightly adapted from the World 
Health Organization’s standard definition), a patient must present with: a temperature of 
38°Celsius or higher and at least one of the following signs and symptoms: cough, sore 
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throat, shortness of breath, or rhinorrhea. Additionally, patients must have been exposed 
through contact within 1 m with a person with a suspected or confirmed case of HPAI H5N1 
within 7 days before symptom onset, close contact with poultry within 7 days of symptoms, 
or close contact with any other animal confirmed to be infected with H5N1 virus; or the 
patient must have handled human or animal laboratory specimens of the HPAI H5N1 virus; 
been diagnosed with leukopenia; had x-ray confirmed rapidly progressing pneumonia; 
possessed an H5 antibody titer for an HI test using horse erythrocytes or enzyme-linked 
immunosorbent assay for influenza A virus (unsubtyped).14,15 Physicians who reported 
making a clinical diagnosis of suspected HPAI H5N1 in outpatients were asked how they 
managed the patient (prescribed antiviral treatment; referred to a designated referral 
hospital; or contacted local district health office, provincial health office, or Ministry of 
Health); response options were not mutually exclusive. If the patient was not prescribed 
antiviral treatment, the physicians were asked to identify reasons for not doing so. 
Physicians were asked if they had ever ordered HPAI H5N1 virus testing on a patient with a 
suspected case or collected clinical specimens for testing. If not, they were asked to provide 
the reasons.
All clinicians were asked if they had heard of the suspect HPAI H5N1 case definition and 
whether they thought a patient with HPAI H5N1 virus infection could die of the illness (yes/
no). Physicians were asked to recall (unaided) the clinical features of HPAI H5N1 virus 
infection in outpatients who present with respiratory disease. Physicians mentioned 
(unaided) which questions about exposure they would ask patients who presented with fever, 
cough, and shortness of breath. They indicated their intention to test for HPAI H5N1 virus if 
patients reported the various types of poultry exposure within the previous 7 days, using a 
Likert-type scale ranging from 1 (very unlikely) to 4 (very likely). Clinicians’ knowledge of 
the recommended antiviral treatment for HPAI H5N1 virus infection was assessed using 
unaided recall (correct answers were oseltamivir and zanamivir). Clinicians indicated 
whether they thought their own knowledge was adequate to diagnose and treat HPAI H5N1, 
as well as whether they had adequate equipment and resources to diagnose and treat HPAI 
H5N1 (yes/no).
As a public health survey, the study was determined to be non-research, not requiring 
institutional review board approval by the US Centers for Disease Control and Prevention.
RESULTS
Reasons for Seeking or Declining Treatment for Symptomatic Household Members
The HUS respondents were evenly divided between East Jakarta and Bogor districts (n = 
1,260 in each district, for a total sample of 2520). Fever/cough was more commonly 
experienced (n = 400) than fever/cough/difficulty breathing (n = 70). As reported in a 
previous study, health care facilities were not heavily used for nonspecific symptoms, and 
slightly less than two-thirds (61%) of households with sick individuals chose to treat 
themselves at home or visit a pharmacy for over-the-counter remedies.12 Preference for 
traditional healers (dukun) had a very low prevalence in this population; less than 6% 
expressed a preference for this source in general and even fewer cited traditional treatment 
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from dukun as appropriate for treating fever/cough (3.4%) or fever/cough/difficulty 
breathing (<1.0%) in family members.
Low concern about symptoms was the primary reason respondents with fever/cough 
declined to visit a health care facility. Approximately half of households with sudden fever/
cough who did not visit a health care facility did not think they were sick enough (55% in 
East Jakarta, 46% in Bogor), or thought they were getting better on their own (22% in East 
Jakarta, 17% in Bogor). A significantly greater proportion of respondents in Bogor (16%) 
did not visit a health care facility for sudden fever/cough because they could not afford it 
compared with those in East Jakarta (6%) (P = .027). Travel distance to facility, lack of 
transportation, lack of time, or inability to leave work to seek care were only rarely cited as 
barriers to seeking treatment for these signs/symptoms (Table 1).
Among those who did seek treatment, the reasons for choosing a particular health care 
facility varied depending on illness severity and urbanicity (Table 1). Perceived quality of 
medicines was an important determinant of choice in treatment facility regardless of illness 
severity for respondents in East Jakarta; nearly half (47%) of respondents with fever/cough 
cited this as a driving factor in their choice of health care facility, and a slightly lower 
proportion of those with fever/cough/difficulty breathing (40%) cited this as a reason. 
Significantly fewer respondents in Bogor identified quality of medicines as a reason for 
choosing a health care facility for fever/cough (28%) compared with those in East Jakarta (P 
= .039), though the proportions were more similar for respondents who experienced fever/
cough/difficulty breathing in Bogor (31%) compared with East Jakarta. Access was the 
second most frequently reported driver of choice of facility for households with fever/cough 
(34% in East Jakarta, 35% in Bogor), but fewer households with fever/cough/difficulty 
breathing cited this as a reason for facility choice (30% in East Jakarta, 20% in Bogor). 
Instead, for households with the acute symptoms of fever/cough/difficulty breathing, cost of 
medications and perceived quality of medicine were cited equally as the second most 
important reasons for choosing a facility (nearly 40% in East Jakarta, 31% in Bogor). Cost 
of services was cited as the third most common reason for choice of facilities in households 
that sought treatment for fever/cough (22% in both districts), followed by cost of 
medications (16% in East Jakarta, 23% in Bogor). Whether medicines were available was 
not cited as a consideration in either district.
Household Perceptions of Clinical Capacity
Among all household respondents (regardless of history of symptoms) (N = 2250), there was 
a relatively high degree of confidence in clinicians’ ability to diagnose and treat HPAI H5N1 
if necessary, though respondents from Bogor expressed significantly higher confidence 
(mean = 3.81, standard error [SE] = 0.04) compared with those in East Jakarta (mean = 3.67, 
SE = 0.03) (Table 2). Though belief was strong in both districts that a person infected with 
HPAI H5N1 could recover if brought to a puskesmas quickly, Bogor respondents expressed 
significantly higher agreement with this statement (mean = 3.56, SE = 0.05) compared with 
those in East Jakarta (mean = 3.12, SE = 0.05).
Among all household respondents (regardless of previous experience with symptoms), those 
in Bogor reported that they would seek treatment if they had a fever (mean = 2.95, SE = 
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0.07) to a greater extent than those to East Jakarta (mean = 2.34, SE = 0.07) (P < .001). 
These measures of intention to seek treatment increased progressively according to whether 
they have a fever and cough (East Jakarta mean = 2.75, SE = 0.08; Bogor mean = 3.22, SE = 
0.07) (P < .001) or fever, sore throat, and difficulty breathing (East Jakarta mean = 3.74, SE 
= 0.04; Bogor mean = 3.60, SE = 0.09). Respondents in Bogor had lower self-reported 
likelihood of seeking treatment when fever, sore throat, and difficulty breathing arose along 
with contact with birds within the previous 2 weeks (mean = 3.47, SE = 0.09), significantly 
less so than East Jakarta (mean = 3.97, SE = 0.06) (p < .001). Similarly, Bogor respondents 
had even lower self-reported likelihood of seeking treatment for these symptoms following a 
visit to a wet market within the previous 2 weeks (mean = 3.34, SE = 0.09), while self-
reported likelihood in East Jakarta remained significantly higher (mean = 3.95, SE = 0.06) 
(P < .001).
Household respondents rarely recalled health care providers ever wanting to test for HPAI 
H5N1 virus (East Jakarta, 7%; Bogor, 4%), and the proportion of respondents who had 
asked for an HPAI H5N1 virus test was nearly zero (Table 2). Awareness of the existence of 
oseltamivir treatment for influenza was low among households in East Jakarta (12% had 
ever heard of it) and Bogor (7%) (P < .002).
Clinician Knowledge of HPAI H5N1 Signs, Symptoms, and Treatment Strategies
A total of 554 clinicians completed survey interviews. As reported elsewhere, the majority 
were general practitioners (88.3%), and the remainder were distributed across sub-
specialties, including obstetrics/gynecology, pediatrics, and internal medicine.12 Over half of 
the sample worked at private hospitals (57%). Those working in government hospitals made 
up the second largest group (20%), and there were smaller numbers from puskesmas (12%) 
and private outpatient clinics (11%). (Table 3).
Nearly all physicians claimed that they were aware of the suspect case definition for HPAI 
H5N1, ranging from 95% in puskesmas to 98% in private hospitals. Physicians almost 
universally recognized the high risk of mortality from HPAI H5N1 virus infection, and 99% 
of clinicians across all facilities believed that a patient with HPAI H5N1 virus infection 
could die of the illness. Fewer physicians in private outpatient clinics correctly recalled key 
signs/symptoms compared with physicians practicing in government facilities (Table 4). 
Fever was the most prominently identified sign or symptom for HPAI H5N1 (recalled by 
91% of clinicians across all facilities). The majority of respondents recognized tight chest 
and congestion as a symptom (73% across all facilities), but only slightly more than one-
third (39%) mentioned difficulty breathing/shortness of breath.
Nearly all (>90%) of the physicians in puskesmas facilities were able to correctly identify 
antiviral medications (oseltamivir or zanamivir) recommended for treatment of HPAI H5N1. 
In contrast, fewer physicians in other facilities were able to recall these antiviral 
medications; 68% of physicians in government hospitals, 62% in private hospitals, and 63% 
in private outpatient clinics had knowledge of the recommended use of these antivirals for 
treatment of HPAI H5N1 patients (P < .001).
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For each facility type, some differences in knowledge of symptoms existed between East 
Jakarta and Bogor (data not shown in tables). Bogor physicians reported difficulty breathing/
shortness of breath as a symptom more than those in East Jakarta; these differences were 
significant in puskesmas (63% of 30 Bogor physicians compared with 26% of 35 physicians 
in East Jakarta; P = .002) and private hospitals (59% of 54 Bogor physicians compared with 
30% of 57 East Jakarta physicians; P = 0.002). There were no significant differences 
between the two districts in identifying fever, cough, or tight chest/congestion.
When asked what questions about exposures over the previous 7 days clinicians would ask 
when encountering a patient with fever, cough, and shortness of breath, slightly more than 
two-thirds of physicians would ask if the patient had handled dead chickens or wild birds 
(ranging from 65% in private outpatient clinics to 77% in puskesmas), whether the patient 
had cared for another patient with suspected HPAI H5N1 virus infection (ranging from 52% 
in puskesmas to 58% in private outpatient clinics), or whether the patient had been exposed 
to wild birds or wild bird feces near the home (ranging from 51% in private clinics to 59% in 
puskesmas). Exposures such as handling live or slaughtered birds at a wet market, eating raw 
poultry, visiting traditional live bird markets, or slaughtering poultry were mentioned less 
frequently (Table 4). Simply going to a wet market within the previous 7 days was rarely 
mentioned as a question physicians would ask (<10% in all facilities); all other questions 
about visiting markets that also included information about handling of poultry or poultry 
meat were asked only slightly more frequently (≤25% or less of respondents in each facility, 
per question) (Table 4).
Case Management of Suspected HPAI H5N1 by Clinicians
All clinicians (N = 554) reported their intentions to test for HPAI H5N1 virus if they learned 
that a patient had specific exposures during the previous 7 days (Table 4). In each facility, 
physicians reported the highest intention to test after learning that a patient had been a 
caregiver to another patient with suspected HPAI H5N1; the average score across facilities 
was 3.47 (SE = 0.03) on a 4-point scale. Appropriately, physicians were least concerned 
about testing for ingestion of cooked chicken or eggs. Wet markets are considered a source 
of exposure since HPAI H5N1 virus is prevalent among birds and poultry and feces with 
HPAI H5N1 virus is a source of contamination, yet physicians expressed lower intentions to 
test for HPAI H5N1 virus in symptomatic patients who reported a recent visit to a wet 
market (mean across all facilities = 2.81, SE = 0.03).
Physicians in Bogor puskesmas had lower intentions to test patients who had recently been 
exposed to poultry compared with their counterparts in Jakarta puskesmas (data not shown 
in tables). These differences were significant when patients had been in a wet market (East 
Jakarta mean = 3.22, SE = 0.09; Bogor mean = 2.76, SE = 0.15; P = .041); handled live birds 
in a wet market (East Jakarta mean = 3.22, SE = 0.09; Bogor mean = 2.73, SE = 0.14; P = .
001), handled slaughtered birds in a wet market (East Jakarta mean = 3.34, SE = 0.11; Bogor 
mean = 2.90, SE = 0.12; P = .004), visited a traditional market where live poultry are sold 
(East Jakarta mean = 3.17, SE = 0.10; Bogor mean = 2.73, SE = 0.13; P = .005), bought 
poultry meat at a traditional market (East Jakarta mean = 3.14, SE = 0.10; Bogor mean = 
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2.73, SE = 0.12; P = .005), and slaughtered chickens (East Jakarta mean = 3.12, SE = 0.09; 
Bogor mean = 2.77, SE = 0.11; P = .009).
Clinician Perceptions of Diagnostic and Treatment Capacity
Clinicians were more confident in their knowledge about recognizing and treating patients 
with HPAI H5N1 virus infection than in their facilities’ diagnostic and treatment resources 
(Table 4). The highest proportion of physicians reporting that they thought their knowledge 
of diagnosis and treatment approaches was adequate were among those working in 
puskesmas (68% reported knowledge of diagnosis, P = .008; 48% for knowledge of 
treatment, P < .001). Physicians expressing the least confidence in their knowledge worked 
in private outpatient clinics (46% thought they had knowledge of how to diagnose; 19% 
thought they had knowledge of treatment approaches).
Physicians were less confident in the diagnostic and treatment resources in their facilities. 
The largest proportion of physicians who believed they had adequate resources to diagnose 
and treat HPAI H5N1 was among those working in government hospitals, but this proportion 
was still relatively low (30% thought they had adequate diagnostic equipment; 25% thought 
they had adequate treatment resources). At least three-quarters of physicians in each facility 
type believed treatment should be administered within 48 hours in order to be effective, and 
this belief was most prevalent among clinicians working in private outpatient clinics (87%) 
(Table 4).
Too few clinicians claimed to have encountered suspected HPAI H5N1 cases (n = 21) to 
compare the frequency of sending patients to referral hospitals or prescribing antivirals 
among facilities. Similarly, too few health care providers ordered HPAI H5N1 tests (n = 6) 
or collected samples (n = 2) to be able to draw inferences about the reasons for doing so; this 
may be an artifact of the relatively low proportion of clinicians surveyed in facilities with the 
testing equipment.
DISCUSSION
This study found that household respondents were confident in clinician capabilities to treat 
HPAI H5N1, believed in the likelihood of recovery if treatment was obtained quickly, and 
cited high-quality, affordable medication and access as priorities in choosing health care 
facilities. Although on average, household members reported that they would hypothetically 
be somewhat likely to seek treatment for fever or fever/cough, the majority of those who had 
experienced nonspecific symptoms (fever and cough) declined to seek treatment, stating 
primarily that they did not believe their symptoms warranted treatment and would get better 
on their own. Respondents in Bogor expressed significantly lower intentions to seek 
treatment compared with those in East Jakarta if they were to have acute symptoms along 
with recent exposure to poultry. Respondents expressed low awareness of the availability of 
antiviral therapy for HPAI H5N1, and very few had ever been tested for the virus. Clinicians 
were knowledgeable about HPAI H5N1 virus infection but felt limited in their ability to test 
or treat for it across facilities; potential gaps in service delivery were identified in some 
facility types.
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Households
Household caregivers attempted to self-treat signs/symptoms that are characteristic of HPAI 
H5N1 virus infection more frequently than they reported seeking treatment at a health care 
facility. It does not appear that the prevalence of self-treatment is due to a public perception 
of clinical shortcomings in the two districts sampled. The data do not demonstrate that an 
anticipated lack of HPAI H5N1 virus testing or treatment directly informs patients’ lack of 
treatment seeking. Patients and caregivers may believe home care is just as effective unless 
they are severely ill. This belief is accurate and advised under most circumstances, except 
that routine contact with poultry is a continuous source of potential exposure to HPAI H5N1 
virus in Indonesia; therefore, vigilance in monitoring signs and symptoms is needed.
Intentions to seek treatment for severe symptoms (fever, sore throat, and difficulty breathing) 
that arise after recent exposure to poultry or wet markets were lower in the rural area of 
Bogor compared with urban East Jakarta, and compared with Bogor respondents’ intentions 
to seek care for less acute symptoms or similarly severe symptoms without recent exposure 
to poultry. This may suggest that regular contact with poultry lowers perceived risk of HPAI 
H5N1 and, therefore, intentions to seek treatment for potential signs/symptoms following 
exposure, and thus warrants further study. This pattern is echoed among physicians in rural 
Bogor, who reported lower intentions to test for HPAI H5N1 virus infection upon learning 
that patients had recent contact with poultry compared with physicians in more urban East 
Jakarta.
This survey was conducted before the 2014 launch of universal health care in Indonesia.16 
Visits to community clinics (puskesmas) and medications were free for those qualifying as 
low income, and private insurance or government schemes (ie, Jamkesmas) provided 
coverage for visits and medications in other facilities. Before the introduction of universal 
health care, a substantial segment of the population (eg, the self-employed or those working 
in the informal sector, including agriculture) was not covered by any insurance because their 
income was too high to qualify for government schemes, but they were unable to afford their 
own insurance.17 Cost of services and medications were mentioned by some respondents as 
a consideration in facility selection or self-treatment, but universal health care will further 
mitigate these barriers. Data on the insured status of respondents in this sample are not 
available.
Clinicians
Clinicians did not demonstrate considerable gaps in knowledge of HPAI H5N1 severity or 
signs/symptoms of HPAI H5N1, but they expressed only a moderate degree of knowledge 
about which questions to ask to assess exposures related to HPAI H5N1 virus transmission. 
Knowledge of treatment (specifically with antiviral medications) was not high in facilities 
besides puskesmas, and purported access to testing and treatment was low. Private outpatient 
clinics seem particularly underresourced in terms of access to antivirals and testing, and 
clinicians in these facilities had the lowest levels of knowledge about HPAI H5N1 signs/
symptoms of any facility. Along with puskesmas, private outpatient clinics are among the 
most heavily used health care facilities by households experiencing fever, cough, and 
difficulty breathing.12 Therefore, private outpatient clinics may represent a gap in service 
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delivery. These frequently used facilities are the least equipped to recognize and treat 
patients with HPAI H5N1. Physicians in private outpatient clinics demonstrated the lowest 
recall of potential HPAI H5N1 signs/symptoms compared with doctors in other facilities, 
and any delay in disease recognition may contribute to high mortality.3,5 These delays could 
interfere with the expedited transfer of patients with suspected HPAI H5N1 to designated 
referral facilities to enable recommended clinical management.
Clinicians’ assessments of inadequacy may reflect a deficit in health system capacity. Given 
the extent to which contact with poultry is common in households, physicians may see 
patients who would meet the HPAI H5N1 case definition when they present with early signs/
symptoms (ie, fever, cough), but it is not feasible to test or treat all such patients as 
suspected cases.
Clinicians exhibited some confusion about their role in testing for HPAI H5N1 virus before 
referring patients to hospitals. Although increased access to HPAI H5N1 virus testing for 
Indonesian health care providers (beyond referral hospitals) has been recommended,3 
clinicians’ confidence in their own diagnostic and testing-related knowledge was 
consistently higher than their perceptions of the resources available to them, among every 
facility type. The self-reported likelihood of HPAI H5N1 virus testing by clinicians may be 
artificially low if it reflects clinicians’ lack of access to tests or understanding of processes, 
rather than a willingness to test upon learning of potential HPAI H5N1 virus exposure. This 
represents a disconnect that may be addressed by physician education about the referral 
process, but it also requires clinician access to proper testing. In practice, testing every 
suspected case may be too costly in terms of time and supplies due to the high prevalence of 
patients with early signs/symptoms who also have recent exposure to poultry.
Recommendations for Health Communication and Medical Education
Health communication efforts can remind the general public that early influenza-like signs/
symptoms must be observed closely for rapid progression to more severe signs and 
symptoms (fever with difficulty breathing) that require urgent medical intervention. 
Messages can also serve as prompts to consider recent exposures, such as visiting wet 
markets, when signs or symptoms develop. Early treatment with oseltamivir has been 
associated with improved survival among those infected with HPAI H5N1 virus, and 
delaying intervention increases risk of mortality.3,4,18 Therefore, household members who 
wait until signs/symptoms are severe to seek treatment may miss an optimal period in which 
oseltamivir treatment can be most clinically beneficial, placing patients at increased risk of 
death from H5N1 HPAI virus infection. Household members were found to have confidence 
in their health care providers, but awareness of antivirals was very low, which may influence 
perceived importance of seeking treatment.
Raising public awareness of antivirals is of limited utility if antivirals are not available in all 
health care facilities, especially if this is the result of policy and supply factors outside the 
control of clinicians or health care facility administration.19 Currently in Indonesia, 
oseltamivir treatment is only recommended for patients hospitalized for strongly suspected 
or confirmed HPAI H5N1 virus infection at designated referral hospitals,9,20 which is 
consistent with our findings among clinicians in nonreferral facilities who believed they had 
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a lower capacity to treat potential HPAI H5N1 cases. Such a strategy is a reasonable 
approach in the context of limited treatment resources, but it magnifies the importance of 
severely ill patients presenting early for treatment (within 48 hours of illness onset).
Physicians expressed awareness of the suspect case definition of HPAI H5N1, but 
identifying potential cases requires knowledge of recent patient exposures. About two-thirds 
of all clinicians mentioned asking whether a symptomatic patient had recently handled dead 
chickens or birds, but there is room for improvement in clinicians’ knowledge of other types 
of poultry exposure (eg, contact with live birds or visiting markets where live poultry is 
sold). Given the very limited human-to-human transmissibility of HPAI H5N1 virus to date, 
clinician respondents may be overemphasizing the likelihood of a patient’s contact with 
another person with suspected HPAI H5N1. Training clinicians on the suspect HPAI H5N1 
case definition and providing more education about the risk of transmission from poultry 
exposures is advised.
Based on the results of this study, it appears that patients mentioning poultry exposures 
could trigger clinician concern about HPAI H5N1 virus exposure and is the key to increasing 
likelihood of testing for HPAI H5N1 virus. Yet, daily contact with poultry is ubiquitous in 
Indonesia, and many patients and physicians may consider at least certain types of contact 
unremarkable. It may be necessary to increase clinician knowledge of the relative risk of 
locations where HPAI H5N1 virus has high prevalence among poultry, such as wet markets.
Limitations
Only two districts were sampled for both surveys and are not nationally representative, 
limiting generalizability. Selection bias was likely present in the clinician survey due to 
issues related to limited access and clinician availability. For the HUS, households were only 
represented by one adult family member and their responses may not have accurately 
reflected the care-seeking attitudes and behaviors of every person in the household. Sample 
sizes for households that experienced acute signs/symptoms were small, further limiting the 
generalizability of results.
CONCLUSIONS
Lack of health care–seeking behavior is not attributable to public perceptions of clinical 
capacity. Clinicians are knowledgeable about human infections with HPAI H5N1 virus, but 
knowledge and diagnostic or treatment capacity vary by facility type. Public health 
campaigns can encourage members of the public to recall possible exposures to poultry 
when they experience signs/symptoms and to mention them to clinicians, and they can also 
raise awareness of the effectiveness of antivirals as a treatment strategy.
Human Subjects Statement
Health Care Utilization Survey: Human subjects review was conducted and approved 
by the Ethics Committee of the Faculty of Public Health, University of Indonesia, with 
additional approval by the Centers for Disease Control and Prevention Institutional Review 
Board, Atlanta, Georgia.
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Clinician Knowledge, Attitudes, and Practices Survey: As a public health survey, 
the study was determined to be nonresearch and not requiring institutional review board 
approval by the US Centers for Disease Control and Prevention.
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TABLE 3
Characteristics of Clinician Participants (N = 554)
Facility Type n (%)
Private hospital 315 (56.9)
Government hospital 111 (20.0)
Community health center (puskesmas) 65 (11.7)
Private outpatient clinic 63 (11.4)
District n (%)
East Jakarta 239 (43.1)
Bogor 315 (56.9)
Years Working at Facility Mean (SE)
Puskesmas 5.1 (0.6)
Government hospital 8.1 (0.3)
Private hospital 5.9 (0.8)
Private outpatient clinic 6.5 (0.3)
Abbreviation: SE, standard error.
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